ATOSSA THERAPEUTICS, INC. 10-K filing
Filed 2026-03-25 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-124396
- Form type
- 10-K
- CIK
- 0001488039
- Primary document
- https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ATOSSA THERAPEUTICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-37.1M | - | - |
| Net Income | $-34.8M | - | - |
| Eps Basic | -4.04 | - | - |
| Eps Diluted | -4.04 | - | - |
| Cash And Equivalents | $41.3M | - | - |
| Total Assets | $47.6M | - | - |
| Total Liabilities | $8.3M | - | - |
| Shareholders Equity | $39.4M | - | - |
| Operating Cash Flow | $-29.8M | - | - |
| Capital Expenditures | $23,000 | - | - |